Analyst Activity – HC Wainwright Reiterates Buy on IntelliPharmaCeutics Intl (NASDAQ:IPCI)

Analyst Ratings For IntelliPharmaCeutics Intl (NASDAQ:IPCI)

Story continues below

Today, HC Wainwright reiterated its Buy rating on IntelliPharmaCeutics Intl (NASDAQ:IPCI) with a price target of $2.50.

Some recent analyst ratings include

  • 2/12/2018-HC Wainwright Reiterated Rating of Buy.
  • 9/26/2017-Mackie Upgrade from a “Hold” rating to a “” rating.
  • 4/18/2017-Aegis Reiterated Rating of Hold.


    Recent Trading Activity for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
    Shares of IntelliPharmaCeutics Intl closed the previous trading session at 0.77 up +0.02 2.13% with 0.7549999952316284 shares trading hands.

    An ad to help with our costs